Recruiting NCT07009327
Efficacy and Safety of Photodynamic Therapy for CIN3
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: ALA-PDT.
- Who it may be relevant to
- Registry conditions: Precancerous Cervical Lesion. Basic parameters: 18 years — 65 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Efficacy and Safety of Photodynamic Therapy for Cervical Intraepithelial Neoplasia 3(CIN3):A Multicenter Prospective Cohort Study
Overview
To investigate the efficacy and safety of photodynamic therapy (20% 5-amino-ketovalerate 630nm red light) in the treatment of cervical intraepithelial neoplasia 3(CIN 3)in women in the real world
Interventions
- Procedure ALA-PDT
use ALA\_PDT to treat the disease
Primary outcome measures
- Efficacy of the treatment [Time frame: 1 month after the treatment]
Eligibility criteria
Inclusion criteria
- CIN3, photodynamic therapy was required,
- type 1 2 transformation area, colposcopy was sufficient
- the lesion boundary was completely visible
- The ECC did not indicate high-grade lesions
Exclusion criteria
- coexistence or suspicion of cancer;
- TCT HSIL
- involving glands
- Porphyria patients, or suspected allergic to red and blue light.
- severe medical comorbidities；
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
China · 1 center
- Peking Unniversity Third Hospital — Beijing
Identifiers
NCT: NCT07009327 · PDT-CIN3 · 2022YFB3604704